Objective: To assess health inequities associated with retinoblastoma across various Socio-Demographic Index (SDI) regions and evaluate whether these inequities have decreased from 1990 to 2021, with the aim of enhancing awareness and guiding government policies.
Design: Population-based demographic analysis.
Participants: Children diagnosed with retinoblastoma from 204 countries and territories.
Methods: The estimates and their 95% uncertainty interval (UI) for disability-adjusted life-years (DALYs) of retinoblastoma were extracted from Global Burden of Disease study (GBD) 2021. The age-standardized DALYs and the average annual percentage change (AAPC) were evaluated.
Main Measures: The Slope Index of Inequality (SII) and concentration index were computed to quantify the absolute and relative cross-national health inequality.
Results: All SDI regions and the majority of countries experienced a significant decline in age-standardized DALYs from 1990 to 2021. The decrease was more rapid in middle to high SDI regions than in low to low-middle SDI regions. Globally, the 2-4 years age group had the highest DALYs rate, consistent with trends in low to middle SDI regions. In contrast, the highest DALYs rate in high and high-middle SDI regions was found in the 12-23 months age group. The SII was -40.81 (95% CI -36.04 to -45.58) DALYs per 100,000 population in 1990 and - 30.32 (95% CI -27.18 to -33.47) DALYs per 100,000 population in 2021. The concentration index increased from -0.37 (95% CI -0.46 to -0.28) in 1990 to -0.45 (95% CI -0.53 to -0.36) in 2021, although this increase did not reach statistical significance ( = 0.256).
Conclusion: Despite advancements in retinoblastoma management, the overall burden of the disease-related DALY remains disproportionately concentrated in poorer populations. The health inequalities are persisting and widening. This underscores the limitations of current efforts. Until progress benefits everyone, the vision of equitable healthcare remains imperfect.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885149 | PMC |
| http://dx.doi.org/10.3389/fpubh.2025.1513526 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The burden of migraine and tension-type headache in Asia from 1990 to 2021.
J Headache Pain
March 2025
Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.
Background: In recent years, headache diseases have spread throughout the world, causing great suffering and even severe disability to patients, and increasing the burden on health care systems. However, studies of specific regions are rare. The purpose of our study is to comprehensively analyze the current situation and trends of headache diseases in Asia between 1990 and 2021, to provide details of headache diseases in Asia, and to provide scientific data to support health development strategies.
View Article and Find Full Text PDFOsteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021.
Sci Rep
March 2025
Department of Orthopedics, Fuzhou Changle District People's Hospital, No. 333 Xiyang South Road, Changle District, Fuzhou, Fujian Province, China.
Osteoarthritis (OA) is a major global health burden, affecting millions and causing significant disability. Understanding its trends and determinants is crucial for effective management and prevention. We analyzed data from the Global Burden of Diseases (GBD) study 2021 to assess OA incidence, Years Lived with Disability (YLDs), and age-standardized rates (ASIR/ASYR) from 1990 to 2021.
View Article and Find Full Text PDFTuberculosis incidence, deaths and disability-adjusted life years in children and adolescence, 1990-2021: Results from the Global Burden of Disease Study 2021.
PLoS One
March 2025
Department of Pharmacy, The 7th People's Hospital of Zhengzhou, Zhengzhou, China.
Background: For a long time, eliminating tuberculosis (TB) has been an enormous challenge in global health. We aim to use the 2021 Global Burden of Disease Study (GBD 2021) to systematically analyze the TB burden in children and adolescents.
Methods: We used the 2021 GBD to retrieve TB incidence, mortality, and disability-adjusted life years (DALYs) data among people aged 0 to19 years in 204 countries and regions between 1990 to 2021.
Global Burden of Major Chronic Liver Diseases in 2021.
Liver Int
April 2025
MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Background: This study utilised the Global Burden of Disease data (2010-2021) to analyse the rates and trends in point prevalence, annual incidence and years lived with disability (YLDs) for major chronic liver diseases, such as hepatitis B, hepatitis C, metabolic dysfunction-associated liver disease, cirrhosis and other chronic liver diseases.
Methods: Age-standardised rates per 100,000 population for prevalence, annual incidence and YLDs were compared across regions and countries, as well as the socio-demographic index (SDI). Trends were expressed as percentage changes (PC) and estimates were reported with uncertainty intervals (UI).
Global burden and trends of viral hepatitis among women of childbearing age from 1990 to 2021.
Front Microbiol
February 2025
Department of Disease Control and Prevention, Jiangmen Municipal Health Bureau, Jiangmen, China.
Background: The burden and trends of viral hepatitis in women of childbearing age (WCBA) are rarely quantified. This study aimed to assess the global, regional, and national incidence and prevalence rates among WCBA from 1990 to 2021.
Methods: From 1990 to 2021, we retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the incidence and prevalence of hepatitis A, B, C, and E for WCBA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!